Latest Coronavirus Disease COVID 19 News and Research
Study: Cellular therapy can improve critical cases of COVID-19
A cellular therapy tested on 13 intubated patients with mechanical ventilation has shown to be efficient for the clinical improvement of critical cases of COVID-19.
COVID cuts a lethal path through San Quentin’s death row
The old men live in cramped spaces and breathe the same ventilated air. Many are frail, laboring with heart disease, liver and prostate cancer, tuberculosis, dementia. And now, with the coronavirus advancing through their ranks, they are falling one after the next.
Analysis: How a COVID-19 vaccine could cost Americans dearly
Yes, of course, Americans' health is priceless, and reining in a deadly virus that has trashed the economy would be invaluable.
In Texas, individual freedoms clash with efforts to slow the surge of COVID cases
The Fourth of July was a little different this year here in Texas' biggest city. Parades were canceled and some of the region's beaches were closed. At the city's biggest fireworks show, "Freedom Over Texas," fireworks were shot higher in the air to make it easier to watch from a distance. Other fireworks displays encouraged people to stay in their cars.
No-biopsy diagnosis for adults with suspected celiac disease could cut long NHS waiting lists
The British Society of Gastroenterology has issued interim guidance, pending the publication of its new Coeliac Guidelines in 2021, so that some adults with suspected coeliac disease can now be diagnosed based on blood test results alone, cutting out the long wait for an endoscopy with biopsy.
OpSec introduces COVID-19 testing kit authentication and traceability solution
OpSec Security, the global leader in physical and digital anti-counterfeiting and brand protection solutions, announces a COVID-19 testing kit authentication and traceability solution.
Innovative clinical trial platform launched to accelerate testing of COVID-19 drugs
The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit announced this week that they have launched their innovative COVID-19 drug testing platform, AGILE.
China reports Dengue fever after bubonic plague threat
The actively spreading coronavirus disease (COVID-19) first emerged in China in December 2019. More than six months after, the world grapples with nearly 11.8 confirmed cases of the viral infection. Now, as China slowly starts to reboot its economy and ease lockdown restrictions, two new health issues are emerging.
Half of coronavirus disease cases could be caused by ‘silent spreaders’
A team of researchers at York University and the Yale School of Public Health evaluated the contribution of pre-symptomatic and asymptomatic transmission to the number of confirmed cases of COVID-19.
_76a7e90c6c6f4195b2cc8ee0244a75cc-150x125.jpg "EPA approves Lysol products that kill SARS-CoV-2 on surfaces")
EPA approves Lysol products that kill SARS-CoV-2 on surfaces
The Environmental Protection Agency (EPA) just approved two disinfection sprays that can kill severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), on surfaces.
Study suggests natural UV radiation protects against coronavirus
A new study by scientists at the University of Edinburgh and published on the preprint server medRxiv* in July 2020 suggests an interesting link between ultraviolet A radiation and deaths due to COVID-19. While this is an observational study, which means that direct inferences cannot be drawn from this finding, it does, however, suggest better strategies for reducing the death rate due to COVID-19.
_70651e87d0a34f6d835e83ff02685f13-150x125.jpg "Study of glycosylation on SARS-CoV-2 spike protein")
Study of glycosylation on SARS-CoV-2 spike protein
The first intimation of the current COVID-19 crisis came with the news of severe pneumonic illness caused by an unknown agent in a Chinese city called Wuhan, issued on the last day of 2019. Following this, researchers found the cause to be a novel coronavirus, closely related to the earlier SARS virus, now called severe acute respiratory syndrome coronavirus 2.
Analysis across 170 countries of Government responses to COVID-19
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Asthma inhalers being trialed for treatment of COVID-19
Researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled corticosteroids, commonly used for asthma patients, on patients with COVID-19. The researchers believe that this could be useful for patients with the novel coronavirus infection.
Many in the UK would refuse a coronavirus vaccine, survey finds
The novel coronavirus pandemic (COVID-19) has left many scientists and pharmaceutical companies racing to develop an effective vaccine to combat the viral infection. With 21 candidate vaccines in clinical evaluation, 139 candidate vaccines in preclinical evaluation across the world, most countries are hoping to be first to the post.
New studies examine outcomes of kidney transplant recipients with COVID-19
Two new studies examine the health and outcomes of patients with COVID-19 who have undergone kidney transplantation or are receiving hemodialysis. The findings appear in an upcoming issue of CJASN.
New standardized codes for healthcare systems released to track coronavirus
LOINC®, created and maintained by the Regenstrief Institute, is amplifying its global work to help track the coronavirus by releasing new standardized codes for healthcare systems' laboratory tests, clinical observations and other data.
Research sheds light on mysterious COVID-19 related hyperinflammatory shock in children
The ongoing COVID-19 pandemic has cost hundreds of thousands of human lives, besides more than 11 million cases. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the disease was initially thought to be more severe in the elderly and those with pre-existing medical conditions. However, it started to manifest in children after the peak of the first wave.
How facemasks protect against COVID-19
The “new normal” is a way of living that helps prevent contracting the novel coronavirus. These include practices such as wearing masks in public places and staying at least six feet from each other. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), can be transmitted via respiratory droplets when a person sneezes, coughs, or talks.
Pitt researchers receive $330,000 to examine the effect of silver-coated fixtures on water disinfection
As workplaces prepare to reopen, precautionary measures like plexiglass barriers and sanitizer stations have been put in place to help prevent the spread of the novel coronavirus.
.png)
No hay comentarios:
Publicar un comentario